Theophylline suppresses the release of interleukin-4 by peripheral blood mononuclear cells

International Archives of Allergy and Immunology

Volumn 115, Issue 1, 1998, Pages 42-46

  Tohda, Yuji ^a   Nakahara, Hiroshi ^a   Kubo, Hirokazu ^a   Muraki, Masato ^a   Fukuoka, Masahiro ^a   Nakajima, Shigenori ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; c AMP; Interleukin 4; Mononuclear cell; Theophylline

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; CYCLIC AMP; INTERLEUKIN 4; PROCATEROL; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; FEMALE; HUMAN; HUMAN CELL; INHALATIONAL DRUG ADMINISTRATION; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RADIOALLERGOSORBENT TEST;

ADULT; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHODILATOR AGENTS; CELLS, CULTURED; CYCLIC AMP; FEMALE; GLYCOPROTEINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RADIOALLERGOSORBENT TEST; THEOPHYLLINE;

EID: 0031964211     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023828     Document Type: Article

References (15)

1. Persson CGA: Some pharmacological aspects on xanthines in asthma. Eur J Respir Dis 1980; 61:7.
2. Rail TW: Drugs used in the treatment of asthma; in Gilman AG, Rall TW, Nies AS, Taylor P (eds): The Pharmacological Basis of Therapeutics, ed 8. New York, Pergamon Press, 1990, p 618.
3. Butcher RW, Sutherland EW: Adenosine 3′,5′-phosphate in biological materials. J Biol Chem 1962;237:1244-1250.
4. Lichtenstein LM, Margolis S: Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 1968;161:902.
5. Kuehl FA Jr, Zanetti ME, Soderman DD, Miller DK, Ham EA: Cyclic AMP-dependent regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis 1987;136: 210-213.
6. Bourne HR, Lichtenstein LM, Melmon KL, Henney CS, Weinstein Y, Shearer GM: Modulation of inflammation and immunity by cyclic AMP. Science 1974;184:19-28.
7. Torphy TJ, Undem BJ: Phosphodiesterase inhibitors: New opportunities for the treatment of asthma. Thorax 1991;46:512-523.
8. Undem BJ, Torphy TJ, Goldman D, Chilton FH: Inhibition by adenosine 3′,5′-monophosphate of eicosanoid and platelet-activating factor biosynthesis in the mouse PT-18 mast cell. J Biol Chem 1990;265:6750-6758.
9. Sullivan P, Bekir S, Jaffer Z, Page C, Jeffery P, Costello J: Anti-inflammatory effects of lowdose oral theophylline in atopic asthma. Lancet 1994;343:1006-1008.
10. Spatafora M, Chiappara G, Merendino AM, D'Amico D, Bellia V, Bonsignore G: Theophylline suppresses the release of tumor necrosis factor-alpha by blood monocytes and alveolar macrophages. Eur Respir J 1994;7:223-228.
11. Banner KH, Page CP: Theophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthma. Eur Respir J 1995;8:996-1000.
12. Schudt C, Tenor H, Hatzelmann A: PDE isoenzymes as targets for anti-asthma drugs. Eur Respir J 1995;8:1179-1183.
13. Barnes PJ, Pauwels RA: Theophylline in the management of asthma: Time for reappraisal? Eur Respir J 1994;7:579-591.
14. Holgate ST, Robinson C, Church MK: The contribution of mast cell mediators to acute allergic reactions human skin and airways. Allergy 1988;43:22-31.
15. Schleimer RP: Glucocorticosteroids: Their mechanisms of action and use in allergic diseases; in Middleton E, Reed CR, Ellis EF, Adkinson NF Jr, Yunginger JW (eds): Allergy Principles and Practice, ed 3, Washington, Mosby, 1988, pp 739-765.